Senseonics (NYSE:SENS) announced today that it filed for CE mark for its Eversense 365 continuous glucose monitor (CGM) ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Paige DeSorbo relies on these sticky push up bra inserts to give her girls ‘a little lift’ and they’re just $17 on Amazon — ...

DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track ...

Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when DexCom (DXCM) reports results for the quarter ended December 2024. While this widely-known consensus outlook ...

Diabetes device expert Steph Habif said her family's experiment with CGMs shows a big opportunity for wearables: intermittent ...

Shares of DexCom Inc. DXCM rose 1.51% to $88.78 Wednesday, on what proved to be an all-around great trading session for the ...

There is no record of Denmark announcing the tariff on Ozempic exports. The social media user who first shared the claim ...

Many or all of the products featured here are from our partners who compensate us. This may influence which ... partners and here's how we make money. Shop Pay, an accelerated checkout function ...

Continuous glucose monitoring (CGM) devices provide real-time blood sugar readings 24 hours a day, allowing people with type 1 or type 2 diabetes to closely track blood glucose levels and trends. Most ...

ITV quiz master Mark Labbett, best known as 'The Beast' on The Chase, has shared an encouraging update on his health journey with fans. The 59-year-old Chaser, who lost a considerable amount of ...

ITV Chaser Mark Labbett has received supportive messages from fans after issuing a health update. The quizzer, 59, has lost a lot of weight in recent years, having been told he was diabetic back ...